Coming soon
NN9924-4635
NN9924-4635
This trial is a 68 week double blind trial evaluating 3 doses of semaglutide in people with type 2 diabetes.
All Research Studies
Enrolling
Oral Insulin
Oral Insulin
Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects with Type 2 Diabetes Mellitus
Enrolling
Ricolinostat
Ricolinostat
Study of Ricolinostat in Patients With Diabetic Neuropathy Pain
Enrolling
Medtronic CIP326
Medtronic CIP326
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Pediatric Subjects
Enrolling
Semaglutide
Semaglutide
Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes
Enrolling
Eli Lilly ITSW
Eli Lilly ITSW
A Study of LY900014 in participants with Type 2 Diabetes using Continuous Glucose Monitoring
Enrolling
GPHD
GPHD
This trial compares the efficacy and safety of tirzepatide once weekly at either 5 mg, 10 mg, 15 mg dose to 3 times a day Lispro in patients with type 2 diabetes on glargine.
Enrolling
Protect – Type 1 Diabetes Study
Protect – Type 1 Diabetes Study
Placebo-Controlled Study to Evaluate Efficacy and Safety of Teplizumab, in Children and Adolescents, Newly Diagnosed Type 1 Diabetes
Enrolling
AbbVie
AbbVie
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events and Efficacy Measures in Hypogonadal Men
On Hold
LY3819253 & LY3832479 COVID-19: Clinical Study
LY3819253 & LY3832479 COVID-19: Clinical Study
Study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19.
Closed
Eli Lilly BDCL
Eli Lilly BDCL
The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.
Closed
Type 1 Diabetes BDCP Clinical Study
Type 1 Diabetes BDCP Clinical Study
Evaluate the Safety of Ly3209590 in Patients with type 1 diabetes being treated with multiple daily injection therapy.
Can’t find a study that works for you?
Subscribe for Information on Other Studies
Fill out the form below an we will let you know when a study becomes available that you may be interested in:
